CMPX-1023

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCMPX-1023

Drug Alias Namealphabody based therapy (Complix NV)nflammation cascade antagonists (Complix NV)CMPX-1023

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionInterleukin-23 inhibitors

TargetsInterleukin-23

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesComplix NV

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesComplix NV

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

ATC CodeN/A